Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma

被引：14

作者：

Bauduer, F ^{[1
]}

机构：

[1] Ctr Hosp Cote Basque, Hematol Serv, Bayonne, France

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 04期

关键词：

thalidomide; plasma cell leukaemia; multiple myeloma;

D O I：

10.1046/j.1365-2141.2002.03537_4.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：996 / 997

页数：2

共 5 条

[1] Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas [J].

Bladé, J ;

Perales, M ;

Rosiñol, L ;

Tuset, M ;

Montoto, S ;

Esteve, O ;

Cobo, F ;

Villela, L ;

Rafel, M ;

Nomdedeu, B ;

Montserrat, E .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :422-424

[2] PRIMARY PLASMA-CELL LEUKEMIA [J].

DIMOPOULOS, MA ;

PALUMBO, A ;

DELASALLE, KB ;

ALEXANIAN, R .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) :754-759

[3] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy [J].

Hideshima, T ;

Chauhan, D ;

Shima, Y ;

Raje, N ;

Davies, FE ;

Tai, YT ;

Treon, SP ;

Lin, B ;

Schlossman, RL ;

Richardson, P ;

Muller, G ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2000, 96 (09) :2943-2950

[4] Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma [J].

Juliusson, G ;

Celsing, F ;

Turesson, I ;

Lenhoff, S ;

Adriansson, M ;

Malm, C .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :89-96

[5] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

← 1 →